OQS
TECH icon

Occudo Quantitative Strategies’s Bio-Techne TECH Stock Holding History

Occudo Quantitative Strategies’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,272
Closed -$445K – 1358
2022
Q3 		$445K Buy
+6,272
New +$542K 0.03% 703

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Occudo Quantitative Strategies's TECH Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 6,272 shares — an estimated $445K sold.

Occudo Quantitative Strategies first reported a position in TECH in Q3 2022 and held it in 1 quarter. The position peaked at $445K in Q3 2022. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 6,272 Bio-Techne shares in Q4 2022, an estimated $445K.
  • Occudo Quantitative Strategies first reported a position in Bio-Techne in Q3 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Bio-Techne position peaked at $445K in Q3 2022.
  • 545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.